Literature DB >> 11180885

Precancerous lesions of intrahepatic cholangiocarcinoma.

T Shimonishi1, M Sasaki, Y Nakanuma.   

Abstract

Intrahepatic cholangiocarcinoma (ICC), also known as cholangiocellular carcinoma or peripheral bile duct carcinoma, is an intrahepatic malignant tumor that consists of cells resembling the biliary epithelium. The proportion of ICC among primary hepatic malignancies is approximately 10% worldwide. Although the etiology and pathogenesis remain unclear in a great majority of cases, preceding pathologic conditions or etiologies in the development of ICC are known or suspected in a proportion of these patients. Some forms of ICC, such as those associated with hepatolithiasis or liver fluke infestation, are endemic in parts of the world, particularly in East Asia. ICC is reportedly a late complication of primary sclerosing cholangitis. Most of these preceding pathologic conditions are forms of chronic cholangitis, and longstanding inflammation, chronic injury, and regenerative hyperplasia of the biliary epithelium may be causally related to malignant transformation. Biliary epithelial dysplasia is encountered in the intrahepatic bile ducts both near and remote from ICC foci in the liver and near and remote from the chronically inflamed biliary tree. This lesion could be a precancerous lesion, and it shows telomerase activity and increased proliferative activities. Furthermore, congenital and developmental disorders of the biliary system, such as Caroli's disease, congenital hepatic fibrosis, and pancreatico-biliary malformation are occasionally associated with ICC. Benign biliary tumors, such as biliary papillomatosis, may eventually undergo malignant transformation. These lesions could be regarded as precancerous or borderline lesions. Some ICCs may also develop in nonbiliary viral cirrhosis. In the majority of cases of ICC, however, the etiology, pathogenesis, and developmental processes and precancerous lesions of the ICC remain unclear.

Entities:  

Mesh:

Year:  2000        PMID: 11180885     DOI: 10.1007/s005340070002

Source DB:  PubMed          Journal:  J Hepatobiliary Pancreat Surg        ISSN: 0944-1166


  25 in total

Review 1.  Large-duct cholangiopathies: aetiology, diagnosis and treatment.

Authors:  Shyam Menon; Andrew Holt
Journal:  Frontline Gastroenterol       Date:  2019-01-04

Review 2.  Epidemiology and risk factors: intrahepatic cholangiocarcinoma.

Authors:  Amar Gupta; Elijah Dixon
Journal:  Hepatobiliary Surg Nutr       Date:  2017-04       Impact factor: 7.293

3.  Upregulated lncRNA-UCA1 contributes to metastasis of bile duct carcinoma through regulation of miR-122/CLIC1 and activation of the ERK/MAPK signaling pathway.

Authors:  Lei Kong; Qinghua Wu; Liangchao Zhao; Jinhua Ye; Nengping Li; Huali Yang
Journal:  Cell Cycle       Date:  2019-05-20       Impact factor: 4.534

4.  Extensive biliary intraepithelial neoplasia (BilIN) and multifocal early intrahepatic cholangiocarcinoma in non-biliary cirrhosis.

Authors:  Anne-Laure Rougemont; Muriel Genevay; Thomas A McKee; Magali Gremaud; Gilles Mentha; Laura Rubbia-Brandt
Journal:  Virchows Arch       Date:  2010-04-29       Impact factor: 4.064

Review 5.  Liver flukes: the malady neglected.

Authors:  Jae Hoon Lim
Journal:  Korean J Radiol       Date:  2011-04-25       Impact factor: 3.500

6.  Clinicopathological features of the intraductal papillary neoplasms of the intrahepatic bile duct.

Authors:  Gi-Woong Jang; Shin Hwang; Yong-Joo Lee; Ki-Hun Kim; Kwang-Min Park; Chul-Soo Ahn; Deok-Bog Moon; Tae-Yong Ha; Gi-Won Song; Dong-Hwan Jung; Gil-Chun Park; Sung-Gyu Lee
Journal:  Korean J Hepatobiliary Pancreat Surg       Date:  2012-11-30

Review 7.  Early detection of intrahepatic cholangiocarcinoma.

Authors:  Mami Hamaoka; Kazuto Kozaka; Osamu Matsui; Takahiro Komori; Takashi Matsubara; Norihide Yoneda; Kotaro Yoshida; Dai Inoue; Azusa Kitao; Wataru Koda; Toshifumi Gabata; Satoshi Kobayashi
Journal:  Jpn J Radiol       Date:  2019-08-01       Impact factor: 2.374

8.  Risk factors for intrahepatic cholangiocarcinoma: a case-control study in China.

Authors:  Yan-Ming Zhou; Zheng-Feng Yin; Jia-Mei Yang; Bin Li; Wen-Yu Shao; Feng Xu; Yu-Lan Wang; Dian-Qi Li
Journal:  World J Gastroenterol       Date:  2008-01-28       Impact factor: 5.742

9.  A case of asymptomatic intraductal papillary neoplasm of the bile duct without hepatolithiasis.

Authors:  Junpei Hayashi; Shyunichi Matsuoka; Makiko Inami; Shu Ohshiro; Akiyasu Ishigami; Hirotoshi Fujikawa; Masahide Miyagawa; Kenji Mimatsu; Youichi Kuboi; Hisao Kanou; Takatsugu Oida; Mitsuhiko Moriyama
Journal:  World J Gastroenterol       Date:  2008-03-14       Impact factor: 5.742

10.  A huge intraductal papillary mucinous carcinoma of the bile duct treated by right trisectionectomy with caudate lobectomy.

Authors:  Won-Joon Sohn; Sungho Jo
Journal:  World J Surg Oncol       Date:  2009-12-05       Impact factor: 2.754

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.